arrow
F

Fang Liu

University of Pennsylvania
H指数:22
被引数:2,430

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study

基于个性化机器学习指导的 Newly Diagnosed Glioblastoma 患者放射剂量递增:前瞻性试点研究

2026-05-130
OAAI
Real-time surveillance system for patient deterioration: a pragmatic cluster-randomized controlled trial

患者恶化实时监测系统:一项实用性集群随机对照试验

2025-04-020
PRE
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR

靶向CCNE1扩增的卵巢癌和子宫内膜癌,通过联合抑制PKMYT1和ATR

2025-04-010
OA
[18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status

[18F]Fluorthanatrace PET在卵巢癌中的应用:与[18F]FDG PET、病灶位置、肿瘤分级和乳腺癌基因突变状态的比较

2024-12-050
PRE
AI-GUIDED PERSONALIZED PRECISION RADIATION THERAPY WITH TARGETED DOSE ESCALATION FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MATCHED-CONTROL STUDY
2024-11-110
PRE
ORIC-613, a potential first- and best-in-class, orally bioavailable, potent and selective PLK4 inhibitor with synthetic lethality in TRIM37 high cancer models
2024-03-220
PRE
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-inhibitor drug-target engagement as a biomarker of response in ovarian cancer

[18F]FluorThanatrace ([18F]FTT) PARP抑制剂药物靶向参与的PET成像作为卵巢癌反应的生物标志物

2023-04-040
PRE
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
2022-11-2815
OA